Save information for later
Sign Up

Learn About Tissue Biopsy

Who are the top Tissue Biopsy Local Doctors?
Urology | Surgical Oncology
Urology | Surgical Oncology

The Regents Of The University Of California

200 Ucla Medical Plz, Suite 140, 
Los Angeles, CA 
 21.4 mi
Offers Telehealth

Mark Litwin is an Urologist and a Surgical Oncologist in Los Angeles, California. Dr. Litwin has been practicing medicine for over 40 years and is rated as an Experienced provider by MediFind in Tissue Biopsy. His top areas of expertise are Prostate Cancer, Bladder Cancer, Urinary Incontinence, Prostatectomy, and Orchiectomy.

Otolaryngology | General Surgery | Plastic Surgery
Otolaryngology | General Surgery | Plastic Surgery

The Regents Of The University Of California

10833 Le Conte Ave, 
Los Angeles, CA 
 21.6 mi

Robert Kang is an Otolaryngologist and a General Surgeon in Los Angeles, California. Dr. Kang has been practicing medicine for over 21 years and is rated as an Experienced provider by MediFind in Tissue Biopsy. His top areas of expertise are Melanoma, Empyema, Angiosarcoma of the Scalp, Bone Marrow Aspiration, and Gastrostomy.

 
 
 
 
Learn about our expert tiers
Learn More
Internal Medicine
Internal Medicine
227 W Janss Rd, Suite 110, 
Thousand Oaks, CA 
 6.0 mi
Offers Telehealth

Jigar Ghelani is an Internal Medicine provider in Thousand Oaks, California. Dr. Ghelani and is rated as an Experienced provider by MediFind in Tissue Biopsy. His top areas of expertise are Hypertension, Familial Hypertension, Glucocorticoid-Remediable Aldosteronism, Colonoscopy, and Gastrostomy.

What are the latest Tissue Biopsy Clinical Trials?
DURVA+ : Evaluation of the Safety and Pharmacodynamics of Anti-PD-L1 Antibody Durvalumab in Combination With Chemotherapy in Patients With Advanced Solid Tumors

Summary: This phase II trial studies the side effects of durvalumab when given together with chemotherapy in treating patients with solid tumors that have spread to other places in the body (advanced). Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, su...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase II Trial of Durvalumab With Gemcitabine and Cisplatin as Neoadjuvant Therapy for High-Risk Resectable Intrahepatic Cholangiocarcinoma

Summary: This phase II trial tests how well giving durvalumab with standard chemotherapy, gemcitabine and cisplatin, before surgery works in treating patients with high risk liver cancer (cholangiocarcinoma) that can be removed by surgery (resectable). Durvalumab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as gemcitabine and cispl...